94 related articles for article (PubMed ID: 9713965)
1. Measurement of the cell proliferation rate of bone marrow erythroid precursors by flow cytometry: initial applications to multiple myeloma.
Timm M; Kimlinger TK; Hanson C; Witzig TE
Leuk Lymphoma; 1998 Jul; 30(3-4):353-9. PubMed ID: 9713965
[TBL] [Abstract][Full Text] [Related]
2. Relation between S-phase fraction of myeloma cells and anemia in patients with multiple myeloma.
Fosså A; Brandhorst D; Myklebust JH; Seeber S; Nowrousian MR
Exp Hematol; 1999 Nov; 27(11):1621-6. PubMed ID: 10560909
[TBL] [Abstract][Full Text] [Related]
3. A quantitative evaluation of erythropoiesis in myelodysplastic syndromes using multiparameter flow cytometry.
Jensen IM; Hokland M; Hokland P
Leuk Res; 1993 Oct; 17(10):839-46. PubMed ID: 8412296
[TBL] [Abstract][Full Text] [Related]
4. Bone marrow infiltration by multiple myeloma causes anemia by reversible disruption of erythropoiesis.
Bouchnita A; Eymard N; Moyo TK; Koury MJ; Volpert V
Am J Hematol; 2016 Jun; 91(4):371-8. PubMed ID: 26749142
[TBL] [Abstract][Full Text] [Related]
5. A new method for the analysis of plasma cell DNA content in multiple myeloma samples using a CD38/propidium iodide double staining technique.
Orfäo A; García-Sanz R; López-Berges MC; Belén Vidriales M; González M; Caballero MD; San Miguel JF
Cytometry; 1994 Dec; 17(4):332-9. PubMed ID: 7533074
[TBL] [Abstract][Full Text] [Related]
6. [Analysis of causes for anemia in patients with multiple myeloma].
Rokicka-Piotrowicz M; Paszkowska M; Król M; Król M; Kuratowska Z
Pol Arch Med Wewn; 2000 Dec; 104(6):843-51. PubMed ID: 11424663
[TBL] [Abstract][Full Text] [Related]
7. Upregulation of erythroblast apoptosis by malignant plasma cells: a new pathogenetic mechanism of anemia in multiple myeloma.
Silvestris F; Cafforio P; Grinello D; Dammacco F
Rev Clin Exp Hematol; 2002; Suppl 1():39-46. PubMed ID: 12735214
[TBL] [Abstract][Full Text] [Related]
8. [Changes in the population composition and the rates of proliferation and specialization of erythroid cells in rats with experimental anemia].
Magakian IuA; Karalova EM; Abroian LO
Tsitologiia; 1993; 35(8):17-23. PubMed ID: 8266571
[TBL] [Abstract][Full Text] [Related]
9. Histologic and cytologic bone marrow findings in dogs with suspected precursor-targeted immune-mediated anemia and associated phagocytosis of erythroid precursors.
Lucidi CA; de Rezende CLE; Jutkowitz LA; Scott MA
Vet Clin Pathol; 2017 Sep; 46(3):401-415. PubMed ID: 28582594
[TBL] [Abstract][Full Text] [Related]
10. [Erythropoiesis in myelodysplastic syndrome detected by multiparameter flow cytometry].
Jensen IM; Jensen PD; Hokland ME; Hokland P; Ellegaard J
Ugeskr Laeger; 1995 Sep; 157(37):5092-6. PubMed ID: 7502376
[TBL] [Abstract][Full Text] [Related]
11. Sickling of nucleated erythroid precursors from patients with sickle cell anemia.
Hasegawa S; Rodgers GP; Dwyer N; Noguchi CT; Blanchette-Mackie EJ; Uyesaka N; Schechter AN; Fibach E
Exp Hematol; 1998 Apr; 26(4):314-9. PubMed ID: 9546314
[TBL] [Abstract][Full Text] [Related]
12. The importance of erythroid expansion in determining the extent of apoptosis in erythroid precursors in patients with beta-thalassemia major.
Centis F; Tabellini L; Lucarelli G; Buffi O; Tonucci P; Persini B; Annibali M; Emiliani R; Iliescu A; Rapa S; Rossi R; Ma L; Angelucci E; Schrier SL
Blood; 2000 Nov; 96(10):3624-9. PubMed ID: 11071663
[TBL] [Abstract][Full Text] [Related]
13. Pure Red Cell Aplasia Associated with Monoclonal Gammopathy of Undetermined Significance and Literature Review.
Gu H; Lee WI; Jeon Y; Kang SY; Kim MH; Park TS
Clin Lab; 2017 Feb; 63(2):373-378. PubMed ID: 28182355
[TBL] [Abstract][Full Text] [Related]
14. A GEIL flow cytometry consensus proposal for quantification of plasma cells: application to differential diagnosis between MGUS and myeloma.
Frébet E; Abraham J; Geneviève F; Lepelley P; Daliphard S; Bardet V; Amsellem S; Guy J; Mullier F; Durrieu F; Venon MD; Leleu X; Jaccard A; Faucher JL; Béné MC; Feuillard J;
Cytometry B Clin Cytom; 2011 May; 80(3):176-85. PubMed ID: 21520405
[TBL] [Abstract][Full Text] [Related]
15. The cell proliferative activity in blood diseases as studied with flow microfluorometry.
Riccardi A
Basic Appl Histochem; 1981; 25(4):313-8. PubMed ID: 6950719
[No Abstract] [Full Text] [Related]
16. Erythroblast apoptosis and microenvironmental iron restriction trigger anemia in the VK*MYC model of multiple myeloma.
Bordini J; Bertilaccio MT; Ponzoni M; Fermo I; Chesi M; Bergsagel PL; Camaschella C; Campanella A
Haematologica; 2015 Jun; 100(6):834-841. PubMed ID: 25715406
[TBL] [Abstract][Full Text] [Related]
17. Flow cytometric assessment of peripheral blood contamination and proliferative activity of human bone marrow cell populations.
Abrahamsen JF; Lund-Johansen F; Laerum OD; Schem BC; Sletvold O; Smaaland R
Cytometry; 1995 Jan; 19(1):77-85. PubMed ID: 7705188
[TBL] [Abstract][Full Text] [Related]
18. Increase of bone marrow cellularity during erythropoietin treatment in myeloma.
Ludwig H; Chott A; Fritz E; Krainer M
Stem Cells; 1995 Aug; 13 Suppl 2():77-87. PubMed ID: 8520516
[TBL] [Abstract][Full Text] [Related]
19. Disease-related anemia in chronic lymphocytic leukemia is not due to intrinsic defects of erythroid precursors: a possible pathogenetic role for tumor necrosis factor-alpha.
Tsopra OA; Ziros PG; Lagadinou ED; Symeonidis A; Kouraklis-Symeonidis A; Thanopoulou E; Angelopoulou MK; Vassilakopoulos TP; Pangalis GA; Zoumbos NC
Acta Haematol; 2009; 121(4):187-95. PubMed ID: 19468203
[TBL] [Abstract][Full Text] [Related]
20. Flow cytometric DNA quantification in immunophenotyped cells as a sensitive method for determination of aneuploid multiple myeloma cells in peripheral blood stem cell harvests and bone marrow after therapy.
Nowak R; Oelschlägel U; Range U; Bergmann S; Bornhäuser M; Hölig C; Schuler U; Krebs U; Günther H; Kroschinsky F; Ehninger G
Bone Marrow Transplant; 1999 May; 23(9):895-900. PubMed ID: 10338044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
